Clinical Trial Update: Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the efficacy and safety of peginterferon alfa-2a in patients with chronic hepatitis B who experienced spontaneous declines in HBV DNA; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Antiviral Treatment of Chronic Hepatitis B | Phase 3 | Status: COMPLETED